REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.15
Bid: 7.80
Ask: 8.50
Change: 0.00 (0.00%)
Spread: 0.70 (8.974%)
Open: 8.15
High: 8.15
Low: 8.15
Prev. Close: 8.15
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of salt reduction technology patent

6 Jun 2016 11:44

RNS Number : 3118A
Tekcapital plc
06 June 2016
 

Tekcapital plc

("Tekcapital")

 

Acquisition of salt reduction technology patent

 

Low-sodium technology aims to reduce salt by up to 50% in surface applications

 

Tekcapital plc (AIM: TEK), an international provider of technology and intellectual property services, announces that it has acquired US patent #8,900,650 B1 for low-sodium salt compositions, which has the potential to enable the commercialisation of a 1:1 replacement for regular salt in a variety of applications including table top, dry snacks such as chips and crisps, popcorn, cereals, and other dry surface applications that have salt in spice mixes.

 

Technology Background

 

Regular salt is not readily soluble in saliva because of its high density and large particles size. When regular salt particles are sprinkled on foods for immediate consumption or during further processing, they provide low- intensity and long-lasting spotty salty tastes. The newly acquired technology delivers an improved dissolution providing equally salty taste as a table-top salt with lower salt concentrations.

 

The directors of Tekcapital believe the patented technology is a novel and safe low-sodium salt solution without using salt substitutes. This innovative nano particle sodium salt does not contain substitutes like calcium, potassium or magnesium salts which can impart the bitter taste typical of most low-sodium salt products. Nano particles dissolve faster and are perceived faster by the consumer thereby allowing for the reduction of the concentration of salt in dry snacks where salt and spices are applied to the surface. The intended result of a commercialised version of this technology would be a sodium reduction of up to 50% depending on the food it is applied to.

 

Key features of a commercialised version of this salt preparation would include: ability to be co-blended with spices, flavours, colours and flow agents; increasing salt dispersion while enhancing salt sensation in the mouth; and stability in all topical applications while imparting increased shelf life.

 

Key benefits of a commercialised version of this salt preparation would include: lower sodium to improve health without sacrificing taste or flavour; helping to meet USDA (US Department of Agriculture) recommended daily allowance recommendations to reduce sodium; and the ability to customise particle size for flexibility in topical coatings.

 

 

Industry potential

 

Food companies are reviewing their global portfolios to reduce sodium in their products. The U.S. Food and Drug Administration (FDA) recently proposed guidelines to reduce sodium consumption by over 30% in the next 10 years.1 According to experts, on average an adult consumes almost 50% more sodium than recommended. Excess sodium could raise blood pressure and is a leading risk factor linked to cardiovascular disease. According to Reuters, roughly 70% of the salt found in diets originate from prepared and processed food, like snack foods and cereals.2 The FDA has established proposed targets for approximately 150 food product categories that the agency said contribute meaningfully to the amount of sodium in the diet.3

 

Recently, Mars Food has stated that it aims to reduce sodium in its products by 20% in the next five years and Nestlé S.A. voiced its support for the FDA's sodium reduction efforts.4

 

Tekcapital has acquired this patent in order to seek, with industry partners, to commercialise the technology. Over the next few weeks Tekcapital will be conducting a taste test of this new product for a leading global food company.

 

Commenting on the patent acquisition, Dr. Clifford M. Gross, Executive Chairman of Tekcapital,

said: "We are excited to have acquired the patent to this novel technology aimed at reducing salt intake in snack foods consumers enjoy without sacrificing the salty taste."

 

 

 

 

 

For further information, please contact:

 

Tekcapital Plc

+1 305 200 3450

 

Clifford M. Gross

info@tekcapital.com

Allenby Capital Limited (Nominated Adviser & Joint Broker)

+44 (0)20 3328 5656

Jeremy Porter / Alex Brearley

Optiva Securities Limited (Joint Broker)

+44 (0) 20 3137 1904

Jeremy King / Vishal Balasingham

jeremy.king@optivasecurities.com

Walbrook PR Ltd

+44 (0) 20 7933 8780

Paul Cornelius / Paul McManus / Helen Cresswell

tekcapital@walbrookpr.com

 

 

Tekcapital plc - The World's Largest University Network for Open Innovation

Tekcapital helps clients profit from new, university-developed intellectual properties. With our proprietary discovery search engine, linked to 4,000+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP, analytics and technology transfer professionals they need to create a competitive advantage. Tekcapital plc is listed on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

 

Cited References

 

1. https://next.ft.com/content/91bd78b2-280c-11e6-8b18-91555f2f4fde

2. http://www.scienceworldreport.com/articles/41251/20160603/new-guidelines-aim-reduce-salt-packaged-food-restaurants.htm

3. http://www.foodbusinessnews.net/-/media/ImagesNew/FoodBusinessNews/Features-2016/6/FDASodiumReduction2_NEW.jpg?la=en

4. http://www.foodbusinessnews.net/articles/news_home/Regulatory_News/2016/06/FDA_issues_sodium_reduction_gu.aspx?ID=%7B136739EA-B31F-4AAC-BCFC-E5024D07213A%7D

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNSRRNAANRAR
Date   Source Headline
2nd Aug 20194:15 pmRNSHolding(s) in Company
1st Aug 201911:35 amRNSHolding(s) in Company
1st Aug 201911:34 amRNSHolding(s) in Company
25th Jul 20197:00 amRNSInvestor Conference Call
22nd Jul 20197:00 amRNSExpansion of Tekcapital services in Mexico
16th Jul 20197:00 amRNSNotice of Investor Conference Call
11th Jul 20197:00 amRNSPlacing to raise £0.75 million
27th Jun 20197:00 amRNSGuident Acquires Additional IP
26th Jun 20197:00 amRNSBelluscura likely to receive FDA clearance in 2019
25th Jun 20197:00 amRNSGuident Acquires Additional IP
24th Jun 20197:00 amRNSSalarius Secures New Order for MicroSalt®
13th Jun 20197:00 amRNSSalarius Secures & Delivers Follow-on Order
14th May 20197:00 amRNSLucyd Launches Loud 2.0 Eyewear Line
3rd May 20197:00 amRNSFlorida Legislature Approves Autonomous Vehicles
29th Apr 20197:00 amRNSGuident Files Additional Patent
24th Apr 20197:00 amRNSPortfolio company, Belluscura plc, raises £500,730
23rd Apr 201911:05 amRNSSecond Price Monitoring Extn
23rd Apr 201911:00 amRNSPrice Monitoring Extension
23rd Apr 20197:00 amRNSSalarius secures first commercial order
5th Apr 20193:12 pmRNSResult of AGM
2nd Apr 20197:00 amRNSStrategic Alliance Agreement with Emprende UP
1st Apr 20197:00 amRNSPortfolio Company Update
25th Mar 20197:00 amRNSPortfolio Company Update
25th Mar 20197:00 amRNSAttendance at UK Investor Show
14th Mar 20197:00 amRNSInvestor conference call
14th Mar 20197:00 amRNSPosting of Annual Report and Notice of AGM
1st Mar 20195:26 pmRNSHolding(s) in Company
26th Feb 20197:00 amRNSUpdate of Research Coverage
26th Feb 20197:00 amRNSNotice of Investor Conference Call
25th Feb 20197:00 amRNSFull Year 2018 Preliminary Results
21st Feb 20197:00 amRNSLucyd Provides Market Update
21st Feb 20197:00 amRNSNotice of Preliminary Results Announcement
19th Feb 20198:52 amRNSBelluscura Files Additional Patent
15th Feb 20193:26 pmRNSHolding(s) in Company
30th Jan 20199:23 amRNSHolding(s) in Company
14th Jan 20197:00 amRNSGuident Ltd Appoints Director
17th Dec 20184:36 pmRNSHolding(s) in Company
12th Dec 20187:00 amRNSUniversity IP webinar
6th Dec 20187:00 amRNSGuident Ltd Appoints Director
3rd Dec 20187:00 amRNSLucyd Signs R Sherman as Chief Brand Officer
26th Nov 20187:00 amRNSMello London
14th Nov 20187:00 amRNSLucyd Launches Affiliate and Reseller Program
8th Nov 201811:34 amRNSHolding(s) in Company
19th Oct 20181:52 pmRNSHolding(s) in Company
18th Oct 20185:25 pmRNSHolding(s) in Company
16th Oct 20185:02 pmRNSHolding(s) in Company
15th Oct 20187:00 amRNSPortfolio Company Update
9th Oct 20187:00 amRNSExecutive Appointment
5th Oct 20187:00 amRNSScience Advisor Appointment
3rd Oct 20187:00 amRNSPublication of Research Note

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.